BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 35566032)

  • 1. Promising Chemotherapy for Malignant Pediatric Brain Tumor in Recent Biological Insights.
    Zhou Q; Xu Y; Zhou Y; Wang J
    Molecules; 2022 Apr; 27(9):. PubMed ID: 35566032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy for malignant brain tumors of childhood.
    Gottardo NG; Gajjar A
    J Child Neurol; 2008 Oct; 23(10):1149-59. PubMed ID: 18952581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Small Molecule Tyrosine Kinases by Polyphenols: New Move Towards Anti-tumor Drug Discovery.
    Sakle NS; More SA; Dhawale SA; Mokale SN
    Curr Drug Discov Technol; 2020; 17(5):585-615. PubMed ID: 31393251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNMTs as potential therapeutic targets in high-risk pediatric embryonal brain tumors.
    Sin-Chan P; Huang A
    Expert Opin Ther Targets; 2014 Oct; 18(10):1103-7. PubMed ID: 25142793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell surface receptors in malignant glioma.
    Li YM; Hall WA
    Neurosurgery; 2011 Oct; 69(4):980-94; discussion 994. PubMed ID: 21522029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecularly targeted therapy for pediatric brain tumors.
    K E W
    J Neurooncol; 2005 Dec; 75(3):335-43. PubMed ID: 16195796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug repurposing towards targeting cancer stem cells in pediatric brain tumors.
    Bahmad HF; Elajami MK; El Zarif T; Bou-Gharios J; Abou-Antoun T; Abou-Kheir W
    Cancer Metastasis Rev; 2020 Mar; 39(1):127-148. PubMed ID: 31919619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy for the treatment of metastatic brain tumors.
    Newton HB
    Expert Rev Anticancer Ther; 2002 Oct; 2(5):495-506. PubMed ID: 12382518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalizing the treatment of pediatric medulloblastoma: Polo-like kinase 1 as a molecular target in high-risk children.
    Triscott J; Lee C; Foster C; Manoranjan B; Pambid MR; Berns R; Fotovati A; Venugopal C; O'Halloran K; Narendran A; Hawkins C; Ramaswamy V; Bouffet E; Taylor MD; Singhal A; Hukin J; Rassekh R; Yip S; Northcott P; Singh SK; Dunham C; Dunn SE
    Cancer Res; 2013 Nov; 73(22):6734-44. PubMed ID: 24019381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conventional chemotherapy and perspectives for molecular-based oncological treatment in pediatric hemispheric low-grade gliomas.
    Fernández MB; Alonso VP
    Childs Nerv Syst; 2016 Oct; 32(10):1939-45. PubMed ID: 27659836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy of brain tumors.
    Prados MD; Russo C
    Semin Surg Oncol; 1998; 14(1):88-95. PubMed ID: 9407635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic Therapy for Lung Cancer Brain Metastases.
    Pellerino A; Bruno F; Rudà R; Soffietti R
    Curr Treat Options Oncol; 2021 Oct; 22(12):110. PubMed ID: 34693454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting tyrosine kinases for treatment of ocular tumors.
    Jo DH; Kim JH; Kim JH
    Arch Pharm Res; 2019 Apr; 42(4):305-318. PubMed ID: 30470974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting ErbB receptors in high-grade glioma.
    Berezowska S; Schlegel J
    Curr Pharm Des; 2011; 17(23):2468-87. PubMed ID: 21827413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of tyrosine kinase inhibitor combinations for glioblastoma therapy.
    Joshi AD; Loilome W; Siu IM; Tyler B; Gallia GL; Riggins GJ
    PLoS One; 2012; 7(10):e44372. PubMed ID: 23056179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The therapy of infantile malignant brain tumors: current status?
    Kalifa C; Grill J
    J Neurooncol; 2005 Dec; 75(3):279-85. PubMed ID: 16195802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy for pediatric brain tumors.
    Kedar A
    Semin Pediatr Neurol; 1997 Dec; 4(4):320-32. PubMed ID: 9447624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The phosphoinositide 3-kinase signaling pathway as a therapeutic target in grade IV brain tumors.
    Höland K; Salm F; Arcaro A
    Curr Cancer Drug Targets; 2011 Oct; 11(8):894-918. PubMed ID: 21861842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer multitarget pharmacology in prostate tumors: tyrosine kinase inhibitors and beyond.
    Bologna M; Vicentini C; Muzi P; Pace G; Angelucci A
    Curr Med Chem; 2011; 18(19):2827-35. PubMed ID: 21651496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Childhood brain tumors: current management, biological insights, and future directions.
    Pollack IF; Agnihotri S; Broniscer A
    J Neurosurg Pediatr; 2019 Mar; 23(3):261-273. PubMed ID: 30835699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.